Adaptimmune Therapeutics PLC·4

Jun 26, 5:00 PM ET

Kerr Giles Francis Bertram 4

4 · Adaptimmune Therapeutics PLC · Filed Jun 26, 2018

Insider Transaction Report

Form 4
Period: 2018-06-22
Transactions
  • Award

    Option to purchase Ordinary Shares

    2018-06-22+124,000124,000 total
    Exercise: $2.18From: 2019-06-22Exp: 2028-06-22Ordinary Shares (124,000 underlying)
Footnotes (1)
  • [F1]The exercise price was converted from GBP1.65 based on an exchange rate of $U.S. 1.3250 to GBP1.00. The actual exercise price will be the pounds sterling amount.

Documents

1 file
  • 4
    a4.xmlPrimary

    4